| Literature DB >> 31909192 |
Ralene Sim1, Izzuddin Aris2, Yap-Seng Chong3, Tien Yin Wong4, Ling-Jun Li3,4.
Abstract
OBJECTIVE: Studies have shown that hypertensive disorders of pregnancy (HDP) are associated with both postpartum retinal microvascular changes and cardiovascular (CV) risks. However, the underlying mechanism of HDP transitioning to microvascular and macrovascular changes remains unknown, due to the interaction between microvasculature and CV risks. In this study, we examined whether associations between antenatal systolic blood pressure (SBP) and postpartum retinal arteriolar changes are independent of postpartum CV risks.Entities:
Keywords: epidemiology; imaging; public health; retina
Year: 2019 PMID: 31909192 PMCID: PMC6936440 DOI: 10.1136/bmjophth-2019-000355
Source DB: PubMed Journal: BMJ Open Ophthalmol ISSN: 2397-3269
Figure 1Directed acyclic graph depicting the traditional four-step mediation analysis using conventional regression approaches. BP, blood pressure.
Characteristics of mothers at baseline (26–28 weeks gestation) and follow-up (5 years after delivery)
| Characteristics at baseline and 5-year follow-up | Total (n=276) |
| Mean, SD or | |
| Baseline at 26–28 weeks gestation | |
| Age, years | 33.0, 4.9 |
| Ethnicity | |
| Chinese | 150 (54.3) |
| Malay | 59 (21.4) |
| Indian | 63 (22.8) |
| College degree, yes | 118 (42.8) |
| Past and current smoker, yes | 22 (8.0) |
| Prepregnancy BMI, kg/m2 | 26.9, 4.1 |
| SBP, mm Hg | 110.4,13.0 |
| GDM diagnosis, yes | 142 (51.4) |
| 5-year postpartum retinal vascular measures | |
| Calibre, µm | 142.8, 9.7 |
| Fractal dimension, df | 1.3, 0.1 |
| Branching angle, degrees | 79.9, 9.4 |
| Curvature tortuosity, unit (×10−5) | 6.9, 2.6 |
| Dilation, % | 3.4, 2.7 |
| Constriction, % | −0.3, 2.7 |
*Student’s t-test (for continuous variables) or χ2 test/Fisher’s exact test (for categorical variables).
BMI, body mass index; df, degrees of freedom; GDM, gestational diabetes mellitus; SBP, systolic blood pressure.
Associations of antenatal systolic blood pressure at baseline and retinal arteriolar structural and functional measures at 5-year follow-up
| Baseline SBP at 26–28 weeks gestation, each 10 mm Hg ↑ | Retinal arteriolar structural and functional measures at 5-year follow-up β (95% CI) | P value |
| Model 1 | −1.0 (−2.1 to 0.03) | 0.06 |
| Model 2 | −1.1 (−2.2 to 0.04) | 0.04 |
| Model 3 | −1.3 (−3.0 to 0.2) | 0.09 |
| Model 1 | −0.5 (−1.0 to 0.02) | 0.04 |
| Model 2 | −0.6 (−1.1 to 0.1) | 0.01 |
| Model 3 | −0.4 (−1.0 to 0.2) | 0.22 |
| Model 1 | 0.7 (−1.2 to 2.6) | 0.46 |
| Model 2 | 0.5 (−1.4 to 2.3) | 0.63 |
| Model 3 | 0.1 (−2.6 to 2.8) | 0.95 |
| Model 1 | −0.2 (−1.3 to 0.9) | 0.76 |
| Model 2 | −0.1 (−1.2 to 1.0) | 0.82 |
| Model 3 | −0.1 (−1.7 to 1.5) | 0.91 |
| Model 1 | 0.2 (−0.1 to 0.5) | 0.23 |
| Model 2 | 0.1 (−0.2 to 0.4) | 0.41 |
| Model 3 | 0.3 (−0.1 to 0.8) | 0.16 |
| Model 1 | 0.3 (0.02 to 0.7) | 0.04 |
| Model 2 | 0.3 (−0.01 to 0.7) | 0.06 |
| Model 3 | 0.5 (0.001 to 1.0) | 0.05 |
Model 1: unadjusted.
Model 2: adjusted for age, ethnicity and college degree.
Model 3: model 2 and additionally adjusted for gestational diabetes mellitus diagnosis and prepregnancy body mass index at baseline (26–28 weeks gestation).
df, degrees of freedom; DVA, dynamic vessel analyser; SBP, systolic blood pressure.
Associations between antenatal systolic blood pressure at baseline and cardiovascular risk score (Framingham Risk Score) at 5-year follow-up
| Baseline SBP at 26–28 weeks gestation, each 10 mm Hg ↑ | 5-year FRS, scores | P value |
| Model 1 | 0.6 (0.07 to 1.2) | 0.03 |
| Model 2 | 0.7 (0.2 to 1.1) | <0.01 |
| Model 3 | 0.7 (0.04 to 1.4) | 0.04 |
Model 1: unadjusted.
Model 2: adjusted for age, ethnicity and college degree.
Model 3: model 2 and additionally adjusted for gestational diabetes mellitus diagnosis and prepregnancy body mass index at baseline (26–28 weeks gestation).
RS, Framingham Risk Score; SBP, systolic blood pressure.
Associations between cardiovascular risk score (FRS) and retinal arteriolar structural and functional measures both at 5-year follow-up
| 5-year FRS, | Retinal microvascular measures at 5-year follow-up β (95% CI) | P value |
| Model 1 | −0.2 (−0.4 to 0.1) | 0.23 |
| Model 2 | −0.02 (−0.3 to 0.3) | 0.92 |
| Model 3 | −0.1 (−0.5 to 0.3) | 0.58 |
| Model 1 | −0.3 (−0.5 to 0.04) | 0.02 |
| Model 2 | −0.2 (−0.5 to 0.1) | 0.15 |
| Model 3 | −0.3 (−0.7 to 0.1) | 0.14 |
| Model 1 | −0.2 (−0.4 to 0.1) | 0.16 |
| Model 2 | −0.2 (−0.5 to 0.1) | 0.27 |
| Model 3 | 0.1 (−0.3 to 0.4) | 0.75 |
| Model 1 | 0.02 (−0.05 to 0.01) | 0.59 |
| Model 2 | 0.05 (−0.04 to 0.14) | 0.27 |
| Model 3 | 0.07 (-0.04 to 0.18) | 0.23 |
| Model 1 | 0.01 (−0.06 to 0.08) | 0.82 |
| Model 2 | −0.02 (−0.1 to 0.07) | 0.59 |
| Model 3 | −0.05 (−0.2 to 0.06) | 0.35 |
Model 1: unadjusted.
Model 2: adjusted for age, ethnicity and college degree.
Model 3: model 2 and additionally adjusted for gestational diabetes mellitus diagnosis and prepregnancy body mass index at baseline (26–28 weeks gestation).
DVA, dynamic vessel analyser; FRS, Framingham Risk Score.